[關(guān)鍵詞]
[摘要]
運(yùn)用中醫(yī)傳承輔助平臺(tái)（V2.5）挖掘分析各省市新型冠狀病毒肺炎（COVID-19）預(yù)防方藥，總結(jié)探討其潛在新方。收集檢索國家及各省、自治區(qū)和直轄市衛(wèi)健委、中醫(yī)藥管理局官方網(wǎng)站關(guān)于COVID-19中醫(yī)藥預(yù)防方案，得到黑龍江、北京、天津、河北、河南、江西、四川、湖北、湖南等17個(gè)省市的COVID-19中醫(yī)藥預(yù)防方案，運(yùn)用頻次統(tǒng)計(jì)、關(guān)聯(lián)規(guī)則、基于熵聚類方法規(guī)律分析等方法進(jìn)行藥物規(guī)律及特點(diǎn)的挖掘。64首處方中共包含82味中藥，使用頻次較高的中藥為黃芪、金銀花等，補(bǔ)虛藥使用最多，多用甘、溫之品，歸肺經(jīng)藥物最多；通過關(guān)聯(lián)規(guī)則分析，得到8個(gè)常用藥物組合；基于熵聚類方法規(guī)律分析得到7個(gè)潛在新方。各地多使用補(bǔ)虛扶正藥物預(yù)防COVID-19，多從肺、脾胃著手，雖具體細(xì)節(jié)不同，但都體現(xiàn)了中醫(yī)學(xué)的預(yù)防思想。
[Key word]
[Abstract]
To dig out and analyze the drug rule of COVID-19 prevention prescriptions from provinces and cities by using Traditional Chinese Medicine Inheritance Support System, summarize and explore its potential new prescription. The Chinese medicine prevention programs for COVID-19 were collected and searched from the official website of the Health Commission and State Administration Medicine of Traditional Chinese Medicine of the country and provinces, autonomous regions, and municipalities. TCM prevention programs in 17 provinces including Heilongjiang, Beijing, Tianjin, Hebei, Henan, Jiangxi, Sichuan, Hubei, and Hunan, etc were received. A total of 82 herbs were included in 64 prescriptions, the most frequently used Chinese herbs were Astragalus membranaceus, Lonicera japonica, etc. Tonifying deficiency drugs with sweet and warm natures were used the most, the Chinese herbs distributed in the lung channel was the most in channel tropism drugs. Analysis by association rule, eight combinations of commonly used drugs were obtained. Based on entropy clustering method rule analysis, seven potential new prescriptions were obtained. Tonifying deficiency drugs are often used in various places to prevent COVID-19, focusing on the lung, spleen and stomach. Although the specific details are different, they all reflect the preventive thinking of traditional Chinese medicine.
[中圖分類號(hào)]
R183.3
[基金項(xiàng)目]
第三屆國醫(yī)大師傳承工作室建設(shè)（003109011001）；川派中醫(yī)眼科名家-廖品正（2015CP017）；基于“道術(shù)結(jié)合”思路與多元融合方法的名老中醫(yī)經(jīng)驗(yàn)傳承創(chuàng)新研究（2018YFC1704100）；西部地區(qū)名老中醫(yī)學(xué)術(shù)觀點(diǎn)、特色診療方法和重大疾病防治經(jīng)驗(yàn)研究（2018YFC1704104）
